Real-time enrollment status for this glioblastoma clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 10:34 PM UTC
| NCT Number | NCT05765812 |
| Recruiting Status | Recruiting |
| Condition | Glioblastoma |
| Phase | PHASE1 |
| Target Enrollment | 116 participants |
| Active Locations | 8 sites in the US |
| Sponsor | Debiopharm International SA |
| Last Updated on CT.gov | June 12, 2026 (Jun 12, 2026) |
As of July 17, 2026: Clinical trial NCT05765812 is currently recruiting participants. This phase1 study for glioblastoma is actively seeking new participants at 8 locations across the United States. The study is sponsored by Debiopharm International SA. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05765812 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 8 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05765812 was last updated Jun 12, 2026 (June 12, 2026). HelloStudys verifies this status automatically.